Sofinnova Capital VII FCPR, 10% Owner at ShockWave Medical, Inc. (SWAV), sold 641,292 shares at $42.67 ($28.3M) on 2020-01-21, disclosed to the SEC on 2020-01-21.
Scheduled sale ($28.3M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.03 | 57,848 | $2.5M | 9.0% |
| 2 | $44.03 | 57,848 | $2.5M | 9.0% |
| 3 | $44.56 | 3,611 | $161K | 0.6% |
| 4 | $44.56 | 3,611 | $161K | 0.6% |
| 5 | $44.58 | 82,383 | $3.7M | 13.0% |
| 6 | $44.58 | 82,383 |
| $3.7M |
| 13.0% |
| 7 | $45.00 | 14,708 | $662K | 2.3% |
| 8 | $42.67 | 38,836 | $1.7M | 5.8% |
| 9 | $42.67 | 38,836 | $1.7M | 5.8% |
| 10 | $43.88 | 53,439 | $2.3M | 8.3% |
| 11 | $43.88 | 53,439 | $2.3M | 8.3% |
| 12 | $44.74 | 77,175 | $3.5M | 12.2% |
| 13 | $44.74 | 77,175 | $3.5M | 12.2% |
| Total | $44.18 avg | 641,292 | $28.3M | 100% |
| Filing → |
| SWAV | SELL | 2020-08-14 | $1.5M | — | Filing → |
| SWAV | SELL | 2020-08-10 | $7.3M | — | Filing → |
| SWAV | SELL | 2020-08-05 | $23.0M | — | Filing → |